OviTex® 2S F10248-1620PRecalls & reported problems
Aroa Biosurgery Limited · The OviTex® Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. OviTex Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device remodels and helps regenerate tissue while reinforcing the repair and providing structural support. Reinforced tissue matrices enhance performance while maintaining compatibility with the body. The OviTex Reinforced Tissue Matrix Device is used for hernia repair and abdominal wall reconstruction. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 09421904065185), received between Oct 11, 2019 and Oct 14, 2019 — classified as 2 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Insufficient Device Problem Information1
Patient problems
- Seroma2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 14, 2019Appropriate Device Problem Term/Code Not Available
A PATIENT WHO UNDERWENT A BRIDGING HERNIA REPAIR WITH OVITEX 2SP ON (B)(6) 2019 PRESENTED WITH A SEROMA APPROXIMATELY TWO WEEKS AFTER SURGERY. IT IS REPORTED THAT THE PATIENT WAS RE-ADMITTED TO THE OPERATING ROOM AND THAT THE SURGEON FOUND THAT THE IMPLANT HAD BEEN PARTIALLY RESORBED OR DIGESTED AND THAT THE SYNTHETIC PORTION REMAINED BEHIND. THE REMAINING PORTIONS WERE EXPLANTED.
Patient problems: Seroma
MAUDE report 9183911 ↗InjuryOct 11, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
A PATIENT WHO UNDERWENT A BRIDGING HERNIA REPAIR WITH OVITEX 2SP ON (B)(6) 2019 PRESENTED WITH A SEROMA APPROXIMATELY TWO WEEKS AFTER SURGERY. IT IS REPORTED THAT THE PATIENT WAS RE-ADMITTED TO THE OR AND THAT THE SURGEON FOUND THAT THE IMPLANT HAD BEEN PARTIALLY RESORBED OR DIGESTED AND THAT THE SYNTHETIC PORTION REMAINED BEHIND. THE REMAINING PORTIONS WERE EXPLANTED.
Patient problems: Seroma
MAUDE report 9181893 ↗
Other Mesh, Surgical, Polymeric devices
- PROCEED PVPMJohnson & Johnson International Inc. · Mesh, surgical, polymeric1,233 reports
- PROCEED PCDN1Johnson & Johnson International Inc. · Mesh, surgical, polymeric744 reports
- PROCEED PCDG1Johnson & Johnson International Inc. · Mesh, surgical, polymeric1 recall1 death637 reports
- PROCEED PVPSJohnson & Johnson International Inc. · Mesh, surgical, polymeric622 reports
- ProGrip LPG1510Sofradim Production · Mesh, surgical, polymeric2 deaths616 reports
- VENTRALEX 0010302Davol Inc. · Mesh, surgical, polymeric4 deaths531 reports
- BARD 0112680Davol Inc. · Mesh, surgical, polymeric1 death494 reports
- ProGrip TEM1509GSofradim Production · Mesh, surgical, polymeric3 deaths471 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page